化学诱变物诱发小鼠脾脏细胞和大麦根端分生组织细胞姐妹染色单体交换的比较研究

诱变剂诱发SCE的增加在大麦细胞中比在小鼠脾脏细胞中所需浓度较低,说明植物SCE比动物体内SCE敏感。所检测的诱变剂大多均能在小鼠脾脏细胞和大麦细胞中诱发SCE的增加,两者之间的SCE/细胞、SCE/pgDNA、SCE比率、SCE/pgDNA增加等项数值均显示极显著相关性,表明所检测的几种诱变剂在小鼠脾脏细胞和大麦细胞中最终诱发SCE的效应是一致的。     

大蒜对环磷酰胺诱发的小鼠骨髓细胞微核和姊妹染色单体交换的保护作用

本文以小鼠骨髓嗜多染红细胞的微核率和小鼠骨髓细胞姊妹染色单体交换(SCE)率两个指标,测定大蒜匀浆滤液(GJ)对环磷酰胺(CP)诱变作用的影响。结果表明,用GJ灌胃处理小鼠能降低CP(30mg/kg)诱发的微核率,差异极显著(P<0.01)。用GJ处理小鼠,除了CP高剂量(30mg/kg)外,CP中和低剂量(3mg/kg和0.3mg/kg)所诱发的SCE率均受到抑制,有显著性差异(P<0.05)。表明大蒜有较强的抗诱变能力,具修复染色体损伤和DNA错误复制的功能。     

初生小鼠脾脏细胞培养制备SCE

近年来,一些实验室多采用外周血、骨髓和睾丸等为材料来制备SCE,尚未见到利用淋巴器官内的淋巴细胞来制备SCE的报道。小鼠是生物学、医学等学科研究中最常用的实验动物之一,作者利用初生小鼠的脾脏细胞体外培养制备SCE,取得了成功。生后3—5天的杂种小白鼠幼鼠,经体表消毒后剖腹取脾脏。除去结缔组织,用Hank's     

苯和环磷酰胺诱发小鼠肝、骨髓和精原细胞染色体畸变的比较分析

在同一个体小鼠上比较分析苯和环磷酰胺诱发的肝、骨髓和精原细胞的染色体畸变率。结果表明,这三种靶细胞的遗传毒理学敏感性是不同的。按每只0.01毫升的剂量皮下注射两次苯于部分肝切除的小鼠,按其诱发的染色体畸变率,敏感性的次序是肝>骨髓>精原细胞。而以环磷酰胺处理的小鼠(15微克/每克体重,腹腔注射),诱发的染色体畸变是骨髓>肝>精原细胞。苯和环磷酰胺诱发的染色体畸变类型无明显差别,主要都是染色单体型的畸变。这种在同一个体小鼠上比较分析三种靶细胞染色体畸变的方法,对于需要肝代谢活化的前致癌剂/前诱变剂活性的测定以及体内比较三种靶细胞的遗传毒性敏感性提供了新的检测途径。 不同组织、器官对化学诱变剂敏感性的差异及其机制的研究,在遗传毒理学中是一项重要的研究课题。 本文试图以苯和环磷酰胺作为检测剂,以同一个体上的肝、骨髓、精原细胞为靶细胞,比较分析诱发的染色体畸变率差异以期对遗传毒理学敏感性有较好的了解。     

丹参凝胶治疗对特应性皮炎小鼠模型皮肤屏障功能、表皮增生以及免疫功能的影响

摘要 目的：研究丹参凝胶治疗对特应性皮炎小鼠模型皮肤屏障功能、表皮增生以及免疫功能的影响。方法：30只C57BL/6小鼠被随机分为Control组、AD组和SG组,每组10只。AD组和SG组背部涂抹对二硝基氟苯建立特应性皮炎小鼠模型,SG小鼠在模型建立成功后涂抹丹参凝胶治疗3周,Control组和AD组涂抹凡士林作为对照。3周后,测量所有小鼠经皮水分丢失量( TEWL) 、皮肤厚度、脾脏指数、胸腺指数,血清IgE、IFN-γ和IL-4,脾脏树突状细胞、Th1和Th2细胞比例。结果：丹参凝胶治疗3周后,AD组和SG组小鼠TEWL、皮肤厚度、脾脏指数、胸腺指数,血清IgE、IFN-γ和IL-4含量,以及脾脏Th2细胞比例均显著高于对照组正常小鼠（P<0.05）,而脾脏树突状细胞、Th1细胞和Th1/Th2细胞比例均显著低于对照组正常小鼠（P<0.05）;与AD组小鼠相比,SG组小鼠TEWL、皮肤厚度、脾脏指数、胸腺指数,血清IgE、IFN-γ和IL-4含量,以及脾脏Th2细胞比例均显著降低（P<0.05）,而脾脏树突状细胞、Th1细胞和Th1/Th2细胞比例均显著升高（P<0.05）。结论：丹参凝胶具有保护特应性皮炎样小鼠皮肤屏障功能和抑制表皮增生的功能,并且可以影响特应性皮炎样小鼠脾脏树突状细胞和辅助性T细胞比例。     

观察小鼠活体骨髓细胞SCE的新技术

姊妹染色单体互换（SCE)离体测试系统 由于易受方法上误差的影响,且不能测出经动 物体内代谢活化系统激活后才能转化为活性致 突变因子,因而离体试验的结果不能完全代表 被测试物的活性诱变效应。为了解决活体SCE 测试中BrdUrd在动物体内迅速降解的问题, 目前一般应用BrdUrd多次注射法或药片埋植 法［[2.31,但手续繁琐且用药量大。Kanda等人 (1979）和Pedro (1980）先后采用吸附BrdUrd 的活性炭注射法观察小鼠活体精原细胞和骨髓 细胞的SCE,使活体SCE技术大为简化［[4,81。我 们在此基础上用IdUrd代替BrdUrd将Pedro的 二次BrdUrd一活性炭注射观察活体骨髓细胞 SCE的方法进一步简化为一次注射,建立了更 为简便的活体SCE检测技术,以适合大规模测 试需要。     

LFA-1缺失诱导小鼠的CD3+细胞上调

淋巴细胞功能相关抗原-1(lymphocyte function-associated antigen 1,LFA-1)是白细胞上的重要粘附分子。本研究旨在探讨LFA-1缺失(LFA-1~(-/-))后小鼠血液、骨髓、脾脏中血液细胞分类和T细胞亚群的变化。本研究采用LFA-1~(-/-)小鼠转基因小鼠,经PCR鉴定其基因型;采用全自动血液检测仪测定血液细胞分类。为进一步了解淋巴细胞亚群的变化,采用流式细胞仪检测LFA-1~(-/-)和对照组小鼠血液、骨髓、和脾脏中T淋巴细胞亚群。结果表明,LFA-1~(-/-)小鼠血液中白细胞总数增多;在骨髓,血液和脾脏中CD3+T淋巴细胞增多。根据研究结果推测LFA-1可能调控CD3+细胞的分化。     

大蒜对环磷酸胺诱发的小鼠骨髓细胞微核和姊妹染色单体交换的保护作用

本文以小鼠骨髓嗜多染红细胞的微核率和小鼠骨髓细胞姊妹染色单体交换（SCE）率两个指标,测定大蒜匀妮滤液(GJ）对环磷酸胺（CP）诱变作用的影响。结果表明,用GJ灌胃处理小鼠能降低CP(30mg/kg)诱发的微核率,差异极显著（P<0.01)。用GJ处理小鼠,除了CP高剂量（30mg/kg)外,CP中和低剂量(3mg/kg和0.3mg/kg)所诱发的SCE率均受到抑制,有显著性差异（P<0.05)。表明大蒜有较强的抗诱变能力,具修复染色体损伤和DNA错误复制的功能。     

黄鳝染色体体内SCE检测系统的建立

应用IdU-毛玉米油体内SCE技术,以不同剂量的典型诱变剂MMC和CP对70尾黄鳝的脾、肾、血淋巴细胞进行了体内诱发SCE敏感性测试。结果:三种细胞的染色体SCE自发频率均较低,不同剂量MMC和CP诱发黄鳝三种细胞SCE频率均较对照组显著增加。诱变剂剂量与诱发SCE频率呈线性关系。三种细胞染色体SCE对MMC和CP的敏感性次序为肾>脾>血淋巴细胞。与几种鱼和其它动物比较,黄鳝三种细胞的SCE自发频率均较低,对MMC和CP诱发SCE的敏感性均较高,因此认为黄鳝可作为较理想的体内SCE检测系统。     

种间胚胎植入对母体免疫系统T细胞比例的影响

目的:研究种间胚胎植入期母体外周血、外周免疫器官(淋巴结、脾脏)、中枢免疫器官(胸腺、骨髓)中总T细胞的百分比变化,并探讨这种变化对种间胚胎植入的影响.方法:利用荧光标记的单克隆抗体染色结合流式细胞术,检测种间、同种胚胎移植以及同期假孕母体外周血、淋巴结、脾脏、胸腺、骨髓中T淋巴细胞的百分率.结果:种间胚胎植入时其外周血T细胞计数极显著低于同种和同期假孕小鼠(P＜0.01),而淋巴结、胸腺、骨髓中的T细胞计数则极显著高于同期假孕小鼠(P＜0.01).脾脏中同种胚胎植入母体则极显著高于种间和同期假孕小鼠(P＜0.01),两后者之间无显著性差异(P＞0.05).结论:种间妊娠时早在植入期开始,母体全身免疫系统就开始发生不利于种间妊娠的反应.     

In vivo and in vivo/in vitro kinetics of cyclophosphamide-induced sister-chromatid exchanges in mouse bone marrow and spleen cells

In several acute and chronic exposures to various chemicals in vivo and in vitro, the average sister-chromatid exchange (SCE) frequencies in human, mouse, rat, and rabbit lymphocytes generally decrease with time following treatment. The rate of this decline varies, but little data have been published pertaining to the comparative kinetics of SCEs both in vivo and in vivo/in vitro (exposure of animals to the test compound and culturing of cells) simultaneously in the same tissues. In this study, a single dose of cyclophosphamide (40 mg/kg) was injected for varying periods (6-48 h) and its effects, as assessed by the induction of SCEs, were analyzed under both in vivo and in vivo/in vitro conditions in mouse bone marrow and spleen cells. In vivo, the cyclophosphamide-induced SCEs increased with increasing time up to 12 h, stayed at approximately the same level until 24 h, and then decreased with increase in post-exposure time. However, the SCE levels remained significantly higher than controls at 48 h post-exposure time in both bone marrow and spleen cells. Under in vivo/in vitro conditions, the SCEs in bone marrow decreased with increase in post-exposure time until reaching control values by 48 h post exposure. However, in spleen cells, the decrease in SCE level was gradual, and by 48 h post-exposure time, the cells still had approximately 6 times higher SCEs than the control values. These results suggest that there are pharmacokinetic differences for cyclophosphamide in mouse bone marrow and spleen. Also, there is a differential SCE response to cyclophosphamide under in vivo and in vivo/in vitro conditions.     

Ah locus-associated differences in induction of sister-chromatid exchanges and in DNA adducts by benzo[a]pyrene in mice.

The effect of alleles of the Ah locus on the induction of sister-chromatid exchanges (SCE) was studied in C57Bl/6 and in DBA/2 mice treated twice intragastrically with benzo[a]pyrene (BP, 100 or 10 mg/kg b.w.). To measure the changes in the frequency of SCE, 2 protocols were used: in vivo in bone marrow cells after implantation of 5-bromodeoxyuridine (BrdU) tablets and in vivo/in vitro in spleen lymphocytes cultured with BrdU. On day 5 mice were killed and SCEs estimated in bone marrow cells. BP-DNA adducts in bone marrow and spleen were analyzed on day 5 after the same exposure to BP. In the spleen lymphocytes SCE frequencies were analyzed after an additional 48 h of culture. We found that at both doses of BP, the number of SCEs and BP-DNA adducts in bone marrow and in spleen cells was significantly higher in aryl hydrocarbon hydroxylase (AHH)-non-inducible (DBA/2) mice than in AHH-inducible (C57BL/6) mice. Only marginal induction of SCE was noted after the high dose of BP in C57BL/6 mice in bone marrow in vivo, whereas a highly significant increase in the frequency of SCEs was found in splenocytes in the in vivo/in vitro test. The spleen cells contained larger amounts of BP-DNA adducts and demonstrated higher absolute levels of SCEs than bone marrow cells. The sensitivity of both the in vivo/in vitro and the in vivo SCE test is high enough for assessment of Ah locus-linked differences in BP genotoxicity in mice at the prolonged time between treatment and cell preparation. The present data confirm the influence of inducibility of AHH in the intestine on the genotoxicity of BP to distal tissues after oral exposure to BP.     

Comparison of the levels of chromosome aberration and sister chromatid exchange induced by chemical mutagens in vitro

Dose dependencies of the induction of sister chromatid exchanges (SCEs) and chromosome aberrations were studied under in vivo exposure of mouse bone marrow cells to 5 alkylating agents. The efficacy of the induction of SCEs for all the substances was 20 to 60 times higher than that of the induction of chromosome aberrations. It was demonstrated that SCEs induced by chemical mutagens in vivo and in vitro are more sensitive tests than chromosome aberrations.     

In vivo sister chromatid exchange analysis of a mouse plasmacytoma cell line NP-38

In vivo sister chromatid exchange (SCE) frequencies have been compared between the mouse plasmacytoma NP-38 and normal bone marrow cells of the host BALB/c mouse. NP-38 cells, transplanted subcutaneously showed a two-fold increase in SCEs (4.35-5.76/cell) compared with the bone marrow cells of the host (1.65-2.14/cell). Such an increase in SCE rates was also observed in NP-38 cells metastasized in spleen, bone marrow, liver, or mesentery, upon inoculation of NP-38 cells by intravenous injection. Even in such tumor-bearing mice, the SCE rates of the bone marrow cells were equivalent to the SCE level found in uninfected mice. These results indicate that the high SCE incidence in NP-38 cells is an inherent characteristic of this tumor cell line.     

Sister-chromatid exchange studies on direct- and indirect-acting clastogens in mouse primary cell cultures

An in vitro sister-chromatid exchange (SCE) assay using mouse primary bone marrow and spleen cells was conducted with both direct- and indirect-acting genotoxic agents. 2,4,7-Trinitrofluorenone, a direct-acting genotoxic agent, induced a significant dose-related increase in SCEs. In both bone marrow and spleen cells, 2.0 micrograms/ml caused an approx. 3-fold increase in SCE level over control values. Cyclophosphamide, an indirect-acting genotoxicant which requires metabolic activation for its clastogenicity, induced a significant increase in SCEs in the presence of S9 from liver of rats pretreated with Aroclor-1254. A dose of 2 micrograms/ml resulted in a 2-fold increase in bone marrow and a greater than 5-fold increase in spleen cells. Benzo[a]pyrene, another indirect-acting genotoxicant, also induced significant dose-related SCE responses in both cell types. It seems that primary bone marrow and spleen cell culture systems can detect both direct- and indirect-acting genotoxicants and may be useful for routine and/or comparative cytogenetic studies.     

In vivo sister chromatid exchange in cells of various organs of the mouse

In vivo sister chromatid exchange (SCE) in mouse cells derived from various organs was studied by infusing BrdU from the tail vein. It was found that at BrdU concentrations ranging from 2.2–13.5 g/g/h, the SCE frequency in bone marrow cells seemed to stay at a constant level (1.5–2/cell/two cell cycles) whereas it started to rise as the BrdU dose exceeded this dose range. When BrdU within this dose range was infused continuously from the tail vein for appropriate hours to label chromosomes in various organs, the average SCE frequencies per cell were found to be 1.64 in bone marrow cells, 1.82 in spermatogonia, 1.99 in splenic cells, 2.89 in intestinal cells and 3.69 in cells from adjuvant stimulated lymph nodes. It is suggested that the spontaneous level of the in vivo SCE frequency might be about 1.5–2/cell/two cell cycles in the mouse. In cells derived from intestine and adjuvant stimulated lymph node, some unknown factors might work as a inducer of SCEs resulting in a significant increase in the SCE frequency in these organs.     

Sister-chromatid exchanges induced by triethylenemelamine: in vivo and in vivo/in vitro studies in mouse and Chinese hamster bone marrow and spleen cells

This study was designed to obtain sister-chromatid exchange (SCE) frequencies in bone marrow and spleen cells of mice and Chinese hamsters under in vivo and in vivo/in vitro systems following treatment of animals with varying doses (15-405 micrograms/kg) of triethylenemelamine (TEM). A dose-related SCE response was found in both species, tissues, and systems analyzed following TEM treatment. In vivo, similar responses were noted for both tissues in both species. However, in vivo/in vitro, the response was lower than in vivo and it varied with the tissue. The spleen cells were more sensitive and gave higher numbers of SCEs than bone marrow of both species at the two highest doses tested (135 and 405 micrograms/kg). These differences may be attributed to cell-culturing effects, type of cells analyzed, species and tissue specificities, and pharmacokinetic properties of the chemical. This study lends support to recently established in vivo/in vitro cell culture methodologies employing mice and Chinese hamsters for comparative cytogenetic analysis.     

Correlation of the sister chromatid exchange level with chromosome aberrations induced by chemical mutagens in vivo

The data on the dose dependencies of the induction of sister chromatid exchanges (SCE) and chromosomal aberrations during exposure of mouse bone marrow cells in vivo to 5 alkylating substances are provided. The efficacy of SCE induction was found to be higher than that of chromosomal aberrations. It was established that SCE induced by chemical mutagens in vivo and in vitro are more sensitive and stable tests than chromosomal aberrations.     

Short-term tests for transplacentally active carcinogens. A comparison of sister-chromatid exchange and the micronucleus test in mouse foetal liver erythroblasts

The effectiveness of 6 chemicals (benzo[a]pyrene, (BaP), cyclophosphamide (CP), diethylnitrosamine (DEN), methyl methanesulphonate (MMS), mitomycin C (MC) and procarbazine (PC) ) as inducers of micronuclei in foetal liver and maternal bone marrow erythroblasts has been determined, and related to that of gamma-radiation. CP, DEN, MMS and PC were all more effective in the foetal liver. The induction of micronuclei and SCEs by each chemical in foetal erythroblasts after in vivo exposure was measured. When expressed as induction of sister-chromatid exchanges (SCEs) per erythroblast/induction of micronuclei per erythroblast (/microM/kg), the ratios obtained were MC 580, BaP 470, DEN 430, CP 258, MMS 140 and PC 13. The lowest doses detected as potentially genotoxic by each test in foetal liver erythroblasts are (with the exception of PC which is a relatively ineffective inducer of SCEs) similar. When isolated foetal livers were exposed in vitro, SCE dose responses to BaP, MC, MMS and PC could be directly related to those from in vivo exposure, indicating the role of the foetal liver in metabolic activation, but CP was considerably more cytotoxic. The transplacental micronucleus test, and in vivo/in vitro method for SCEs in foetal liver erythroblasts, provide sensitive, complementary assays for genotoxic effects of chemicals during prenatal life. Since foetal liver possesses greater metabolic potential than adult bone marrow, the transplacental tests respond to genotoxic agents not detected by bone-marrow systems.